Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-09-12 Purchase | 2024-09-16 4:18 pm | Century Therapeutics Inc. | IPSC | Quimi Daphne Director | 5,000 | $1.5314 | $7,657 | 5,000 (Direct) | View |
2024-08-05 Sale | 2024-08-07 4:06 pm | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 1,073 | $1.827 | $1,960 | 136,163 (Direct) | View |
2024-08-05 Sale | 2024-08-07 4:06 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 289 | $1.827 | $528 | 334,041 (Direct) | View |
2024-07-26 Sale | 2024-07-31 09:08 am | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 586 | $2.5 | $1,465 | 367,706 (Indirect Direct) | View |
2024-07-23 Sale | 2024-07-25 5:04 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 1,800 | $2.5164 | $4,529 | 368,292 (Indirect Direct) | View |
2024-06-20 Sale | 2024-06-24 4:49 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 5,000 | $2.8357 | $14,179 | 370,092 (Indirect Direct) | View |
2024-06-05 Sale | 2024-06-06 4:53 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 5,000 | $2.9978 | $14,989 | 375,092 (Indirect Direct) | View |
2024-05-20 Sale | 2024-05-21 4:09 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 5,000 | $2.9955 | $14,978 | 380,092 (Indirect Direct) | View |
2024-05-06 Sale | 2024-05-07 5:13 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 5,000 | $3.1238 | $15,619 | 385,092 (Indirect Direct) | View |
2024-05-03 Sale | 2024-05-07 5:13 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 257 | $3.106 | $798 | 317,323 (Direct) | View |
2024-05-03 Sale | 2024-05-07 5:13 pm | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 913 | $3.106 | $2,836 | 137,236 (Direct) | View |
2024-04-22 Sale | 2024-04-24 4:17 pm | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 5,000 | $3.0979 | $15,490 | 390,092 (Indirect Direct) | View |
2024-03-06 Sale | 2024-03-08 6:29 pm | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 53,515 | $5.0394 | $269,682 | 474,290 (Direct) | View |
2024-02-16 Sale | 2024-02-21 4:10 pm | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 485 | $4.8624 | $2,358 | 336,319 (Direct) | View |
2024-02-05 Sale | 2024-02-07 5:21 pm | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 1,200 | $4.1409 | $4,969 | 303,580 (Direct) | View |
2024-02-05 Sale | 2024-02-07 5:21 pm | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 3,819 | $4.1428 | $15,821 | 114,149 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-10-14 Option Award | 2024-10-16 4:58 pm | N/A 2034-10-14 | Century Therapeutics Inc. | IPSC | Conn Morgan Chief Finanical Officer | 421,038 | $0 | 421,038 (Direct) | View |
2024-10-01 Option Award | 2024-10-03 6:04 pm | N/A 2034-10-01 | Century Therapeutics Inc. | IPSC | Cowan Chad Chief Scientific Officer | 520,626 | $0 | 667,753 (Direct) | View |
Ownership | 2024-10-03 6:04 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Cowan Chad Chief Scientific Officer | 0 | $0 | 147,127 (Direct) | View |
2024-06-20 Option Award | 2024-06-21 4:51 pm | N/A 2034-06-20 | Century Therapeutics Inc. | IPSC | JIMENEZ JOSEPH Director | 44,000 | $0 | 44,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-21 4:51 pm | N/A 2034-06-20 | Century Therapeutics Inc. | IPSC | Walbert Timothy P Director | 44,000 | $0 | 44,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-21 4:50 pm | N/A 2034-06-20 | Century Therapeutics Inc. | IPSC | Quimi Daphne Director | 44,000 | $0 | 44,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-21 4:50 pm | N/A 2034-06-20 | Century Therapeutics Inc. | IPSC | BUTITTA CYNTHIA M Director | 44,000 | $0 | 44,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-21 4:50 pm | N/A 2034-06-20 | Century Therapeutics Inc. | IPSC | Riva Alessandro Director | 44,000 | $0 | 44,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-21 4:49 pm | N/A 2034-06-20 | Century Therapeutics Inc. | IPSC | Carlo Rizzuto Director | 44,000 | $0 | 44,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-21 4:48 pm | N/A 2034-06-20 | Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director | 44,000 | $0 | 44,000 (Direct) | View |
2024-06-07 Option Award | 2024-06-10 4:36 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 17,007 | $0 | 334,330 (Direct) | View |
2024-03-07 Option Award | 2024-03-18 5:48 pm | N/A 2034-03-07 | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 121,975 | $0 | 1,575,254 (Direct) | View |
2024-03-07 Option Award | 2024-03-11 7:38 pm | N/A 2034-03-07 | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 95,000 | $0 | 398,580 (Direct) | View |
2024-03-07 Option Award | 2024-03-11 7:36 pm | N/A 2034-03-07 | Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks | 170,000 | $0 | 541,092 (Direct) | View |
2024-03-07 Option Award | 2024-03-11 7:35 pm | N/A 2034-03-07 | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 170,000 | $0 | 284,149 (Direct) | View |
2024-03-07 Option Award | 2024-03-11 7:34 pm | N/A 2034-03-07 | Century Therapeutics Inc. | IPSC | Levitsky Hyam President of R&D | 170,000 | $0 | 706,544 (Direct) | View |
2024-03-06 Exercise | 2024-03-08 6:29 pm | N/A 2029-07-17 | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 53,515 | $0 | 474,290 (Direct) | View |
2024-03-06 Exercise | 2024-03-08 6:29 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 53,515 | $1.03 | 474,290 (Direct) | View |
2024-02-16 Exercise | 2024-02-21 4:10 pm | N/A 2029-07-17 | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 485 | $0 | 336,319 (Direct) | View |
2024-02-16 Exercise | 2024-02-21 4:10 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 485 | $1.03 | 336,319 (Direct) | View |
2023-12-04 Option Award | 2023-12-06 4:07 pm | N/A 2033-12-04 | Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO | 2,026,970 | $0 | 2,026,970 (Direct) | View |
2023-11-01 Tax Withholding | 2023-11-03 4:04 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations | 16,611 | $1.49 | 304,780 (Direct) | View |
2023-11-01 Tax Withholding | 2023-11-03 4:04 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Diem Michael Craig Chief Financial Officer | 20,763 | $1.49 | 253,533 (Direct) | View |
2023-06-27 Option Award | 2023-06-29 4:23 pm | N/A 2024-06-27 | Century Therapeutics Inc. | IPSC | Carlo Rizzuto Director | 44,000 | $0 | 44,000 (Direct) | View |
2023-06-27 Option Award | 2023-06-29 4:22 pm | N/A 2024-06-27 | Century Therapeutics Inc. | IPSC | Riva Alessandro Director | 44,000 | $0 | 44,000 (Direct) | View |
2023-06-27 Option Award | 2023-06-29 4:21 pm | N/A 2024-06-27 | Century Therapeutics Inc. | IPSC | JIMENEZ JOSEPH Director | 44,000 | $0 | 44,000 (Direct) | View |